Literature DB >> 1330617

Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney.

I Heuzé-Joubert1, P Mennecier, S Simonet, M Laubie, T J Verbeuren.   

Abstract

In isolated Tyrode-perfused rat kidneys, the release of the cyclic nucleotides cAMP and cGMP was measured in response to several vasodilators, including nitric oxide (NO). During vasoconstrictions induced by methoxamine, a basal release of both cyclic nucleotides was detected in the renal effluent (357 +/- 32 fmol/min for cGMP and 3097 +/- 219 fmol/min for cAMP). Injection of acetylcholine (ACh; 11 nmol), sodium nitroprusside (SNP; 0.8 nmol) and atrial natriuretic factor (ANF; 80 pmol) caused a marked release of cGMP. The cGMP release induced by ACh was not altered by indomethacin (3 microM) but was markedly reduced by the NO synthase inhibitor nitro-L-arginine (L-NNA; 200 microM). Authentic NO (0.16-80 nmol) caused dose-dependent vasodilatations that were accompanied by increases in the overflow of cGMP. The vasodilatations caused by forskolin (6 nmol) and prostacyclin (PGI2; 3-52 nmol) were not accompanied by an overflow of cGMP. The vasodilator responses to 5-hydroxytryptamine (5-HT; 0.25-2 mumol), obtained in presence of the 5-HT2 receptor blocker ritanserin (10 nM) and the 5-HT3 blocker ICS 205930 (10 nM), were markedly reduced by L-NNA; however, they were not accompanied by the renal release of cGMP. Both forskolin and PGI2 induced the release of cAMP from perfused rat kidneys; ACh, 5-HT and 5-carboxamidotryptamine (5-CT) also evoked a significant release of cAMP into the renal effluent. The release of cAMP induced by ACh and 5-HT was reduced by indomethacin and L-NNA. Higher doses of NO released cAMP from the perfused rat kidneys. Our data illustrate that both cAMP and cGMP can be released by vasodilator substances into the venous effluent of isolated perfused rat kidneys. The dilator responses to 5-HT were sensitive to the NO synthase inhibitor L-NNA and were accompanied by the release of cAMP and not by the release of cGMP. Our data suggest that the dilator responses may be due to NO released from endothelial cells, which then activates adenylyl cyclase either directly or indirectly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330617     DOI: 10.1016/0014-2999(92)90744-o

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  KCa 3.1 channels maintain endothelium-dependent vasodilatation in isolated perfused kidneys of spontaneously hypertensive rats after chronic inhibition of NOS.

Authors:  Serge Simonet; Marc Isabelle; Mélanie Bousquenaud; Nicolas Clavreul; Michel Félétou; Christine Vayssettes-Courchay; Tony J Verbeuren
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

2.  Regulation of 3',5'-cAMP in preglomerular smooth muscle and endothelial cells from genetically hypertensive rats.

Authors:  Dongmei Cheng; Jin Ren; Delbert G Gillespie; Zaichuan Mi; Edwin K Jackson
Journal:  Hypertension       Date:  2010-10-25       Impact factor: 10.190

3.  Contribution of nitric oxide to beta2-adrenoceptor mediated vasodilatation in human forearm arterial vasculature.

Authors:  N G Majmudar; D Anumba; S C Robson; G A Ford
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

4.  Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms.

Authors:  Tsuyoshi Morishita; Masato Tsutsui; Hiroaki Shimokawa; Ken Sabanai; Hiromi Tasaki; Osamu Suda; Sei Nakata; Akihide Tanimoto; Ke-Yong Wang; Yoichi Ueta; Yasuyuki Sasaguri; Yasuhide Nakashima; Nobuyuki Yanagihara
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-15       Impact factor: 11.205

5.  Nitric oxide activates cyclooxygenase enzymes.

Authors:  D Salvemini; T P Misko; J L Masferrer; K Seibert; M G Currie; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

6.  Involvement of endogenous nitric oxide in the mechanism of bradykinin-induced peripheral hyperalgesia.

Authors:  A Nakamura; M Fujita; H Shiomi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

7.  Relaxation mechanisms induced by stimulation of nerves and by nitric oxide in sheep urethral muscle.

Authors:  A García-Pascual; D Triguero
Journal:  J Physiol       Date:  1994-04-15       Impact factor: 5.182

8.  Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.

Authors:  A E Eckly; C Lugnier
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

9.  Regulation of renovascular adenosine 3',5'-cyclic monophosphate in spontaneously hypertensive rats.

Authors:  Edwin K Jackson; Zaichuan Mi
Journal:  Hypertension       Date:  2009-06-15       Impact factor: 10.190

10.  Comparison of Elaeagnus angustifolia Extract and Sildenafil Citrate on Female Orgasmic Disorders: A Randomized Clinical Trial.

Authors:  Marzieh Akbarzadeh; Sanaz Zeinalzadeh; Jaleh Zolghadri; Abdolali Mohagheghzadeh; Pouya Faridi; Mehrab Sayadi
Journal:  J Reprod Infertil       Date:  2014-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.